Editor’s (re)View: BMS, Merck, Roche see manufacturing flexibility as key to dealing with tariffs
Apr 30, 2025•4 min•Ep. 82
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The three Big Pharma companies on their earnings calls this week tried to reassure investors that they have the global footprints to mitigate the effects of tariffs.
For the best experience, listen in Metacast app for iOS or Android